
浏览全部资源
扫码关注微信
1.重庆医科大学附属第二医院放射科,重庆400010
2.陆军军医大学第一附属医院放射科,重庆400038
3.陆军军医大学第一附属医院乳腺甲状腺外科,重庆400038
陈林丽,E-mail:282343684@ qq. com
收稿:2026-01-05,
修回:2026-09-16,
录用:2026-04-28,
纸质出版:2026-10-25
移动端阅览
范锐,贺星云,杜俊泽等.基于临床病理特征预测甲状腺乳头状癌喉前淋巴结转移的列线图模型构建[J].局解手术学杂志,2026,35(10):854-859.
FAN Rui,HE Xing-yun,DU Jun-ze,et al.Construction of a nomogram model based on clinicopathological features for predicting delphian lymph node metastasis of papillary thyroid carcinoma[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2026,35(10):854-859.
范锐,贺星云,杜俊泽等.基于临床病理特征预测甲状腺乳头状癌喉前淋巴结转移的列线图模型构建[J].局解手术学杂志,2026,35(10):854-859. DOI: 10.11659/jjssx.01E026014.
FAN Rui,HE Xing-yun,DU Jun-ze,et al.Construction of a nomogram model based on clinicopathological features for predicting delphian lymph node metastasis of papillary thyroid carcinoma[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2026,35(10):854-859. DOI: 10.11659/jjssx.01E026014.
目的
2
基于临床诊疗中易获取的临床病理特征,筛选甲状腺乳头状癌(PTC)患者喉前淋巴结转移的独立危险因素,并构建及验证列线图预测模型,为术前风险分层和个体化手术决策提供参考。
方法
2
回顾性分析271例PTC患者的临床资料,按7∶3的比例随机分为训练集(
n
=189)和验证集(
n
=82)。收集患者临床资料,采用单因素和多因素Logistic回归分析筛选喉前淋巴结转移的独立危险因素,构建列线图预测模型。通过受试者工作特征(ROC)曲线、校准曲线和决策曲线分析(DCA)分别评估模型的区分度、校准度和临床实用性。
结果
2
多因素Logistic回归分析显示,肿瘤位于中份、多发PTC、中央区淋巴结转移和男性是喉前淋巴结转移的独立危险因素。基于上述独立危险因素构建的列线图模型在训练集和验证集中的曲线下面积(AUC)分别为0.866(95%
CI
:0.815~0.917)和0.833(95%
CI
:0.746~0.919),显示出良好的区分度。校准曲线显示模型预测概率与实际概率具有良好的一致性,DCA证实该模型具有较高的临床净收益。
结论
2
肿瘤位于中份、多发PTC、中央区淋巴结转移和男性是PTC患者喉前淋巴结转移的独立危险因素。基于以上因素构建的列线图模型能够有效预测PTC患者喉前淋巴结转移风险,可为临床个体化治疗决策提供参考依据。
Objective
2
To screen the independent risk factors for delphian lymph node metastasis in patients with papillary thyroid carcinoma(PTC) based on readily available clinicopathological characteristics in daily clinical practice,and a nomogram prediction model was constructed and verified to provide references for preoperative risk stratification and individualized surgical decisions.
Methods
2
A retrospective analysis was conducted on the clinicopathological data of 271 PTC patients. All participants were randomly divided into the training set(
n
=189) and the validation set(
n
=82) at a 7∶3 ratio. The clinical data of patients were collected. Univariate and multivariate Logistic regression analyses were used to identify the independent risk factors for delphian lymph node metastasis,and a nomogram prediction model was established. Receiver operating characteristic(ROC) curve,calibration curve and decision curve analysis(DCA) were applied to evaluate the discrimination,calibration and clinical applicability of the model,respectively.
Results
2
Multivariate Logistic regression analysis revealed that tumor location in the middle,multifocal PTC,central lymph node metastasis and male gender were the independent risk factors for delphian lymph node metastasis. The area under the curve(AUC) of the nomogram model constructed based on the above independent risk factors was 0.866(95%
CI
: 0.815 to 0.917) in the training set and 0.833(95%
CI
: 0.746 to 0.919) in the validation set,suggesting good discriminatory ability. Calibration curves showed good consistency between model-predicted probability and actual incidence. DCA confirmed that the model possessed favorable clinical net benefit.
Conclusion
2
Tumor location in the middle, multifocal PTC,central lymph node metastasis and male gender are the independent risk factors for delphian lymph node metastasis in patients with PTC. The nomogram model constructed based on the above factors can effectively predict the risk of delphian lymph node metastasis in patients with PTC and provide a reference basis for individualized clinical treatment decisions.
Chen Y , Wang Y , Li C , et al . Meta-analysis of the effect and clinical significance of delphian lymph node metastasis in papillary thyroid cancer [J]. Front Endocrinol , 2024 , 14 : 1295548 . doi: 10.3389/fendo. 2023. 1295548 http://dx.doi.org/10.3389/fendo.2023.1295548 .
Sung H , Ferlay J , Siegel RL , et al . Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin , 2021 , 71 ( 3 ): 209 - 249 . doi: 10.3322/caac.21660 http://dx.doi.org/10.3322/caac.21660 .
Cabanillas ME , McFadden DG , Durante C . Thyroid cancer [J]. Lancet , 2016 , 388 ( 10061 ): 2783 - 2795 . doi: 10.1016/S0140-6736(16)30172-6 http://dx.doi.org/10.1016/S0140-6736(16)30172-6 .
Pavlidis ET , Pavlidis TE . Role of prophylactic central neck lymph node dissection for papillary thyroid carcinoma in the era of de-escalation [J]. World J Clin Oncol , 2023 , 14 ( 7 ): 247 - 258 . doi: 10.5306/wjco.v14.i7.247 http://dx.doi.org/10.5306/wjco.v14.i7.247 .
Zhu Y , Lin J , Yan Y , et al . Delphian lymph node metastasis is a novel indicator of tumor aggressiveness and poor prognosis in papillary thyroid cancer [J]. J Surg Oncol , 2021 , 123 ( 7 ): 1521 - 1528 . doi: 10.1002/jso.26380 http://dx.doi.org/10.1002/jso.26380 .
Haugen BR , Alexander EK , Bible KC , et al . 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer [J]. Thyroid , 2016 , 26 ( 1 ): 1 - 133 . doi: 10.1089/thy.2015.0020 http://dx.doi.org/10.1089/thy.2015.0020 .
Huang J , Sun W , Zhang H , et al . Use of delphian lymph node metastasis to predict central and lateral involvement in papillary thyroid carcinoma: a systematic review and meta-analysis [J]. Clin Endocrinol(Oxf) , 2019 , 91 ( 1 ): 170 - 178 . doi: 10.1111/cen.13965 http://dx.doi.org/10.1111/cen.13965 .
Qi Q , Xu P , Zhang C , et al . Nomograms combining ultrasonic features with clinical and pathological features for estimation of delphian lymph node metastasis risk in papillary thyroid carcinoma [J]. Front Oncol , 2021 , 11 : 792347 . doi: 10.3389/fonc.2021.792347 http://dx.doi.org/10.3389/fonc.2021.792347 .
Yu KJ , Wu XJ , Dai L , et al . Risk factors associated with lymph node metastasis in papillary thyroid cancer: a retrospective analysis based on 2,428 cases [J]. Front Oncol , 2024 , 14 : 1473858 . doi: 10.3389/fonc. 2024.1473858 http://dx.doi.org/10.3389/fonc.2024.1473858 .
Feng JW , Qu Z , Qin AC , et al . Significance of multifocality in papillary thyroid carcinoma [J]. Eur J Surg Oncol , 2020 , 46 ( 10 Pt A ): 1820 - 1828 . doi: 10.1016/j.ejso.2020.06.015 http://dx.doi.org/10.1016/j.ejso.2020.06.015 .
Cui YQ , Li YM , Yin XL , et al . Significance and predictive value of delphian lymph node in papillary thyroid carcinoma [J]. Curr Med Imaging , 2025 , 21 : e15734056360214 . doi: 10.2174/011573405636 0214250215155608 http://dx.doi.org/10.2174/0115734056360214250215155608 .
Wu Q , Wei Y , Zhao Z , et al . Characterization of thyroid lymphatic drainage on real-time contrast-enhanced ultrasound: a mapping study in vivo [J]. Ann Anat-Anat Anz , 2026 , 264 : 152765 . doi: 10.1016/j.aanat.2025.152765 http://dx.doi.org/10.1016/j.aanat.2025.152765 .
Wei Y , Niu Y , Zhao ZL , et al . Effectiveness of lymphatic contrast enhanced ultrasound in the diagnosis of cervical lymph node metastasis from papillary thyroid carcinoma [J]. Sci Rep , 2022 , 12 ( 1 ): 578 . doi: 10.1038/s41598-021-04503-1 http://dx.doi.org/10.1038/s41598-021-04503-1 .
Wang F , Yu X , Shen X , et al . The prognostic value of tumor multifocality in clinical outcomes of papillary thyroid cancer [J]. J Clin Endocrinol Metab , 2017 , 102 ( 9 ): 3241 - 3250 . doi: 10.1210/jc. 2017-00277 http://dx.doi.org/10.1210/jc.2017-00277 .
Gao Y , Tian M , Hou X , et al . Multifocality increases the risk of central compartment lymph node metastasis but is not related to the risk of recurrence and death in papillary thyroid carcinoma [J]. Gland Surg , 2024 , 13 ( 12 ): 2383 - 2394 . doi: 10.21037/gs-2024-505 http://dx.doi.org/10.21037/gs-2024-505 .
Hao Y , Su Y , Li Y , et al . Construction of a predictive model for cervical lymph node metastasis in papillary thyroid carcinoma [J]. Front Oncol , 2025 , 15 : 1549148 . doi: 10.3389/fonc.2025.1549148 http://dx.doi.org/10.3389/fonc.2025.1549148 .
Hu R , Ren Q , Li T , et al . Evidence-based integration of clinicopathological factors with the risk of papillary thyroid carcinoma lateral cervical lymph node metastasis: systematic review and meta-analysis and subgroup study [J]. Gland Surg , 2025 , 14 ( 5 ): 912 - 928 . doi: 10.21037/gs-2025-60 http://dx.doi.org/10.21037/gs-2025-60 .
Huang C , Zhou J , Zhuang Y , et al . The clinical value of delphian and pre-tracheal lymph nodes in predicting lateral lymph nodes metastasis of papillary thyroid carcinoma [J]. Ann Med , 2025 , 57 ( 1 ): 2444551 . doi: 10.1080/07853890.2024.2444551 http://dx.doi.org/10.1080/07853890.2024.2444551 .
Li X , Duan Y , Liu D , et al . Diagnostic model incorporating clinicopathological characteristics of delphian lymph node metastasis risk profiles in papillary thyroid cancer [J]. Front Endocrinol , 2021 , 12 : 591015 . doi: 10.3389/fendo.2021.591015 http://dx.doi.org/10.3389/fendo.2021.591015 .
Feng JW , Zheng F , Liu SQ , et al . Preoperative prediction of occult level V lymph node metastasis in papillary thyroid carcinoma: development and validation of a radiomics-driven nomogram model [J]. Acad Radiol , 2025 , 32 ( 3 ): 1360 - 1372 . doi: 10.1016/j.acra. 2024.10.001 http://dx.doi.org/10.1016/j.acra.2024.10.001 .
Zhu J , Huang R , Yu P , et al . Male gender is associated with lymph node metastasis but not with recurrence in papillary thyroid carcinoma [J]. Int J Endocrinol , 2022 : 1 - 9 . doi: 10.1155/2022/3534783 http://dx.doi.org/10.1155/2022/3534783 .
Li M , Maso LD , Vaccarella S . Global trends in thyroid cancer incidence and the impact of overdiagnosis [J]. Lancet Diabetes Endocrinol , 2020 , 8 ( 6 ): 468 - 470 . doi: 10.1016/S2213-8587(20)30115-7 http://dx.doi.org/10.1016/S2213-8587(20)30115-7 .
Zhou C , Xu C , Yang B , et al . Preoperative US integrated random forest model for predicting delphian lymph node metastasis in patients with papillary thyroid cancer [J]. Curr Med Imaging , 2023 , 19 ( 9 ): 1031 - 1040 . doi: 10.2174/1573405619666230105150219 http://dx.doi.org/10.2174/1573405619666230105150219 .
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621